Nuclear translocation of telomerase reverse transcriptase: A critical process in chemical induced hepatocellular carcinogenesis

Neoplasma

Volumn 57, Issue 3, 2010, Pages 222-227

  Chen, Y ^a,b   Kong, Q ^a,b  

^a HENAN INSTITUTE OF SCIENCE AND TECHNOLOGY   (China)

^b Shandong Lanjin Bioengineering Co Ltd   (China)

Author keywords

Hepatocellular carcinoma; Telomerase; Telomerase reverse transcriptase; TERT translocation

Indexed keywords

DIETHYLNITROSAMINE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENE TRANSLOCATION; IMMUNOFLUORESCENCE; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING; ACTIVE TRANSPORT; ANIMAL; CELL NUCLEUS; CHEMICALLY INDUCED DISORDER; LIVER TUMOR; METABOLISM; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; DIETHYLNITROSAMINE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; TELOMERASE;

EID: 77954643534     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_03_222     Document Type: Article

References (41)

1. HARLEY CB, VILLEPONTEAU B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995; 5: 249-255. doi:10.1016/0959-437X(95)80016-6
2. SHAY JW, BACCHETTI S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-791. doi:10.1016/ S0959-8049(97)00062-2
3. MASSARD C, ZERMATI Y, PAULEAU AL, LAROCHETTE N. MÉTIVIER D. et al. hTERT: A novel endogeneous inhibitor of the mitochondrial cell death pathway. Oncogene 2006; 25: 4505-4514. doi:10.1038/sj.onc.1209487
4. HANAHAN D, WEINBERG RA. The hallmarks of cancer. Cell 2000; 100: 57-70. doi:10.1016/S0092-8674(00)81683-9
5. BERMUDEZ Y, ERASSO D, JOHNSON NC, ALFONSO MY, LOWELL NE et al. Telomerase confers resistance to caspase-mediated apoptosis. Clin Interv Aging 2006; 1: 155-167. doi:10.2147/ciia.2006.1.2.155
6. FENG J, FUNK WD, WANG SS, WEINRICH SL, AVILLION AA, et al. The RNA component of human telomerase. Science 1995; 269(5228): 1236-1241. doi:10.1126/science.7544491
7. BODNAR AG, OUELLETTE M, FROLKIS M, HOLT SE, CHIU CP, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279(5349): 349-352. doi:10.1126/science.279.5349.349
8. VAZIRI H, BENCHIMOL S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8: 279-282. doi:10.1016/S0960-9822(98)70109-5
9. WANG S, ZHU J. The hTERT gene is embedded in a nuclease-resistant chromatin domain. J Biol Chem 2004; 279: 55401-55410. doi:10.1074/jbc.M411352200
10. ZHANG C, GUO X, JIANG G, ZHANG L, YANG Y, et al. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma. Int J Cancer 2008; 123: 998-1004. doi:10.1002/ijc.23650
11. MIURA N, MAEDA Y, KANBE T, YALAMA H, TAKEDA Y, et al. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res 2005; 11: 3205-3209. doi:10.1158/1078-0432.CCR-04-1487
12. PELLICCIOTTA I, CORTEZ-GONZALEZ X, SASIK R, REITER Y, HARDIMAN G, et al. Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. Cancer Res 2008; 68: 8085-8093. doi:10.1158/0008-5472.CAN-08-1014
13. LIU K, HODES RJ, WENG NP. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 2001; 166: 4826-4830.
14. BRANDT S, HELLER H, SCHUSTER KD, GROTE J. The tamoxifen-induced suppression of telomerase activity in the human hepatoblastoma cell line HepG2: a result of posttranslational regulation. J Cancer Res Clin Oncol 2005; 131: 120-128. doi:10.1007/s00432-004-0589-0
15. WONG, J. M., KUSDRA, L. AND COLLINS, K. Subcellular shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 2002; 4, 731-736. doi:10.1038/ncb846
16. KYO S, MASUTOMI K, MAIDA Y, KANAYA T, YATABE N. et al. Significance of immunological detection of human telomerase reverse transcriptase: reevaluation of expression and localization of human telomerase reverse transcriptase. Am J Path 2003; 163: 859-867.
17. LEPREUX S, DOUDNIKOFF E, AUBERT I, BIOULACSAGE P. BLOCH B. et al. Cytoplasmic expression of human telomerase catalytic protein (hTERT) in nuetrophils: an immunoelectron microscopy study. Ultrastruct Pathol 2008; 32: 178-183. doi:10.1080/01913120802034504
18. MASUTOMI K, YU EY, KHURTS S, BEN-PORATH I, CURRIER JL. et al. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-253. doi:10.1016/ S0092-8674(03)00550-6
19. SANTOS JH, MEYER JN, SKORVAGA M, ANNAB LA, VAN HOUTEN B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004; 3: 399-411. doi:10.1111/j.1474-9728.2004.00124.x
20. OHSHIMA H, BARTCH H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-264. doi:10.1016/0027-5107(94)90245-3
21. SOLT D, FARBER E. New priciple for the analysis of chemical carcinogenesis. Nature 1976; 263: 701-703. doi:10.1038/263701a0
22. DINSER R, KREPPEL F, ZAUCKE F, BLANK C, PAULSSON M. et al. Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochem Cell Biol 2001; 116: 69-77.
23. LAU WK, YEUNG CW, LUI PW, CHEUNG LH, POON NT. Different trends in modulation of NMDAR1 and NMDAR2B gene expression in cultured cortical and hippocampal neurons after lead exposure. Brain Res 2002; 932: 10-24. doi:10.1016/ S0006-8993(01)03395-9
24. SQUIRE RA, LEVITT MH. Report of a workshop in classification of specific hepatocellular lesions in rats. Cancer Res 1975; 35(11 Pt 1): 3214-3223.
25. LEE CM, HSU CY, ENG HL, HUANG WS, LU SN. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Hepatogastroenterology 2004; 51: 796-800.
26. SHIMOJIMA M, KOMINE F, HISATOMI H, SHIMIZU T, MORIYAMA M. et al. Detection of telomerase activity, telomerase RNA component, and telomerase reverse transcriptase in human hepatocellular carcinoma. Hepatol Res 2004; 29: 31-38. doi:10.1016/j.hepres.2004.02.005
27. TAKAHASHI S, KITAMOTO M, TAKAISHI H, AIKATA H, KAWAKAMi Y. et al. Expression of telomerase component genes in hepatocellular carcinomas. Eur J Cancer 2000; 36: 496-502. doi:10.1016/S0959-8049(99)00284-1
28. OH BK, KIM H, PARK YN, YOO JE, CHOI J, et al. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Invest 2008; 88: 144-152. doi:10.1038/labinvest.3700710
29. WEGE H, BRUMMENDORF TH. Telomerase activation in liver regeneration and hepatocarcinogenesis: Dr. Jekyll or Mr. Hyde? Curr Stem Cell Res Ther 2007; 2: 31-38. doi:10.2174/ 157488807779317062
30. MASUTOMI K, YU EY, KHURTS S, BEN-PORATH I, CURRIER JL. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-253. doi:10.1016/S0092-8674(03)00550-6
31. ELMORE LW, NORRIS MW, SIRCAR S, BRIGHT AT, MCCHESNEY PA et al. Upregulation of telomerase function during tissue regeneration. Exp Biol Med 2008; 233: 958-967. doi:10.3181/0712-RM-345
32. AHMED S, PASSOS JF, BIRKET MJ, BECKMANN T, BRINGS S, et al. Telomerase does not counteract telomere shorting but protects mitochondrial function under oxidative stress. J Cell Science 2008; 121: 1046-1053. doi:10.1242/jcs.019372
33. RAHMAN R, LATONEN L, WIMAN KG. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene 2005; 24: 1320-1327. doi:10.1038/sj.onc.1208232
34. LIU JP. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 1999; 13: 2091-2104.
35. LI H, ZHAO L, YANG Z, FUNDER JW, LIU JP. Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem 1998; 273: 33436-33442. doi:10.1074/ jbc.273.50.33436
36. HAENDELER J, HOFFMANN J, RAHMAN S, ZEIHER AM, DINMER S. Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett 2003; 536: 180-186. doi:10.1016/ S0014-5793(03)00058-9
37. KAWAUCHI K, IHJIMA K, YAMADA O. IL-2 Increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. J Immunol 2005; 174: 5261-5269.
38. MINAMINO T, MITSIALIS SA, KOUREMBANAS S. Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 2001; 21: 3336-3342. doi:10.1128/MCB.21.10.3336-3342.2001
39. LI H, ZHAO LL, FUNDER JW, LIU JP. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 1997; 272: 16729-16732. doi:10.1074/ jbc.272.27.16729
40. Kalala JP, Maes L, Vandenbroecke C, De Ridder L. The hTERT protein as a marker for malignancy in meningiomas. Oncol Rep 2005; 13: 273-277.
41. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004; 94: 768-775. doi:10.1161/01. RES.0000121104.05977.F3